Main Study

Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements

OMB: 0910-0785

IC ID: 214502

Documents and Forms
Document Name
Document Type
Other-Questionnaire
Information Collection (IC) Details

View Information Collection (IC)

Main Study CDER
 
No Modified
 
Voluntary
 
21 CFR 202.1(e)(5)(i) 21 CFR 202.1(e)(6)(i) 21 CFR 202.1(e)(3)(ii)

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Other-Questionnaire 0785 Questionnaire Revised 10-15-2015.docx Yes Yes Fillable Fileable Signable

Health Consumer Health and Safety

 

1,500 0
   
Individuals or Households
 
   100 %

  Approved Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 1,500 0 0 0 0 1,500
Annual IC Time Burden (Hours) 750 0 0 0 0 750
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Title Document Date Uploaded
No associated records found
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.

© 2024 OMB.report | Privacy Policy